The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation

被引：1

作者：

Shouval, Daniel ^{[1
]}

机构：

[1] Hadassah Hebrew Univ Hosp, Liver Unit, Jerusalem, Israel

来源：

JOURNAL OF HEPATOLOGY | 2014年 / 61卷 / 02期

关键词：

HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION; BRIDGE;

D O I：

10.1016/j.jhep.2014.05.012

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

下载

页码：190 / 192

页数：3

共 43 条

[21] Administered activity and outcomes of glass versus resin Y-90 microsphere radioembolization in patients with colorectal liver metastases
Srinivas, Shyam M.
Nasr, Elie C.
Kunam, Vamsi K.
Bullen, Jennifer A.
Purysko, Andrei S.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 530 - 539
[22] Liver Contouring Technique Comparison for Y90 Microspheres Liver Radioembolization for Patients with Non-HCC Liver Disease
Alvarez, D.
Gandhi, R.
Chuong, M.
Gutierrez, A.
MEDICAL PHYSICS, 2020, 47 (06) : E810 - E810
[23] The response and survival rates of Y-90 radioembolization in patients with unresectable liver tumors; a single-centre experience
Ekmekcioglu, O.
Tabakci, O.
Simsek, D. Has
Bayrak, A. Hasanefendioglu
Bilgic, S.
Berk, G.
Simsek, C.
Kaplan, N.
Battal, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S60 - S60
[24] 90Y PET/CT for dosimetry measurement and quantitative optimization in inoperable HCC patients treated by 90Y glass microspheres radioembolization
Chen, Sirong
Leung, Wai Tong
Cheung, William
Cheng, Kam
Wong, Ka Nin
Leung, Yim Lung
Wong, Yuet Hung
Ho, Chi-Lai
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[25] Absorbed Dose in "Black Hole" as a predict of complete MRI response in HCC patients treated with Y-90 TARE
Meyer, M.
Boughdad, S.
Prior, J. O.
Da Mota, M.
Schaefer, N.
Hocquelet, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S472 - S473
[26] Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for Y-90 resin microspheres
Kennedy, Andrew S.
Ball, David
Cohen, Steven J.
Cohn, Michael
Coldwell, Douglas M.
Drooz, Alain
Ehrenwald, Eduardo
Kanani, Samir
Rose, Steven C.
Nutting, Charles W.
Moeslein, Fred M.
Savin, Michael A.
Schirm, Sabine
Putnam, Samuel G., III
Sharma, Navesh K.
Wang, Eric A.
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (02) : 134 - +
[27] Pretreatment albumin may help select patients for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver.
Orwat, Kelly Elizabeth
Cooper, Samuel Lewis
Ashenafi, Michael
Anderson, M. Bret
Guimaraes, Marcelo
Marshall, David T.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[28] European multicenter evaluation of survival for patients with hepatocellular carcinoma (HCC) treated by radioembolization with 90y-labeled resin microspheres
Sangro, B.
Carpanese, L.
Cianni, R.
Golfieri, R.
Gasparini, D.
Ezzidin, S.
Hoffman, R.
Fiore, F.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[29] Gemcitabine plus Cisplatin versus non-gemcitabine and Cisplatin as neo-adjuvant for cholangiocarcinoma patients prior to liver transplantation
Abdelrahim, M.
Esmail, A.
Xu, J.
Saharia, A.
McMillan, R.
Kodali, S.
Umoru, G.
Ghobrial, R. M.
TRANSPLANTATION, 2022, 106 (8S) : 158 - 158
[30] PROSPECTIVE ASSESSMENT OF LIVER HEALTH FOLLOWING LIVER RESECTION AND Y-90 RADIOEMBOLIZATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA USING MULTI-PARAMETRIC MRI PLATFORM
Fichera, Alessandro
Connell, John
Nunez, Luis
Pickels, Elisabeth
Ng, David C. E.
Gogna, Apoorva
Goh, Brian
Tai, David Wai Meng
Toh, Han Chong
Choo, Su Pin
Chan, Wan Ying
Hennedige, Tiffany Priyanthi
Tan, Iain Bh
Lo, Richard Hg
Yan, Sean Xx
Chua, Clarinda
Koo, Si Lin
Lim, Kiat Hon
Latiff, Julianah A.
Chua, Huang S.
Choon, Thng H.
Banerjee, Rajarshi
Brady, Michael
Kelly, Matt
Chow, Pierce
HEPATOLOGY, 2021, 74 : 710A - 710A

← 1 2 3 4 5 →